| Literature DB >> 35640584 |
Anna K Gergen1, Cenea Kemp1, Christian V Ghincea1, Zihan Feng1, Yuki Ikeno1, Muhammad Aftab1, T Brett Reece1.
Abstract
BACKGROUND: Selective antegrade cerebral perfusion (SACP) has become our preferred method for cerebral protection during open arch cases. While the initial approach involved sewing a graft to the innominate artery as the arterial cannulation site, our access strategy has since evolved to central aortic cannulation with use of a percutaneous cannula in the innominate for SACP. We hypothesized that SACP delivered via direct innominate cannulation using a 12- or 14-Fr cannula results in equivalent outcomes to cases utilizing a side graft.Entities:
Year: 2022 PMID: 35640584 PMCID: PMC9179210 DOI: 10.1055/s-0042-1744136
Source DB: PubMed Journal: Aorta (Stamford) ISSN: 2325-4637
Fig. 1Central cannulation via the ascending aorta is utilized for establishment of cardiopulmonary bypass and initiation of cooling. Prior to circulatory arrest, the innominate artery is accessed with a needle and upsized to a 12- or 14-Fr cannula. Once the patient reaches the desired temperature, circulatory arrest ensues. The base of the innominate artery is occluded and selective antegrade cerebral perfusion is delivered via the 12- or 14-Fr cannula.
Baseline characteristics of patients undergoing aortic hemiarch replacement using selective antegrade cerebral perfusion via a 10-mm side graft sutured to the innominate artery versus direct innominate cannulation using a 12- or 14-Fr cannula
| Side graft | Direct cannulation | ||||
|---|---|---|---|---|---|
| Absolute value | Percentage | Absolute value | Percentage | ||
|
| 171 | 40 | – | ||
| Age (y) | 58.3 ± 15.0 | 59.9 ± 12.9 | 0.536 | ||
|
| 0.681 | ||||
| Male | 130 | 76.0 | 32 | 80.0 | |
| Female | 41 | 24.0 | 8 | 20.0 | |
|
| 0.174 | ||||
| Caucasian | 137 | 80.1 | 36 | 90.0 | |
| Black/Other | 34 | 19.9 | 4 | 10.0 | |
| Body mass index | 28.9 ± 6.3 | 29.1 ± 6.9 | 0.854 | ||
| Baseline creatinine | 0.9 ± 0.3 | 1.3 ± 1.8 |
| ||
| Hypertension | 110 | 64.3 | 25 | 62.5 | 0.856 |
| Diabetes | 19 | 11.1 | 8 | 20.0 | 0.185 |
| Stroke | 9 | 5.3 | 0 | 0.0 | 0.213 |
| Chronic kidney disease | 13 | 7.6 | 3 | 7.5 | > 0.999 |
| Coronary artery disease | 26 | 15.2 | 4 | 10.0 | 0.463 |
| Dyslipidemia | 67 | 39.2 | 17 | 42.5 | 0.722 |
| Pulmonary disease | 31 | 18.1 | 9 | 22.5 | 0.508 |
| Peripheral vascular disease | 2 | 1.2 | 2 | 5.0 | 0.163 |
| Smoking | 58 | 33.9 | 11 | 27.5 | 0.575 |
| Symptomatic on presentation | 68 | 39.8 | 19 | 47.5 | 0.379 |
| Redo sternotomy | 20 | 11.7 | 4 | 10.0 | > 0.999 |
|
| 0.554 | ||||
| Aortic root replacement | 71 | 41.5 | 18 | 45.0 | |
| Isolated aortic valve replacement/repair | 62 | 36.3 | 15 | 37.5 | |
|
Other
| 35 | 20.5 | 5 | 12.5 | |
Note: Values are presented as mean ± standard deviation (SD) unless otherwise specified.
Coronary artery bypass grafting, mitral valve repair, mitral valve replacement, patent foramen ovale closure, aortic annulus enlargement, and/or atrial fibrillation procedure.
Intraoperative and postoperative outcomes following elective aortic hemiarch replacement using selective antegrade cerebral perfusion via a 10-mm side graft sutured to the innominate artery versus direct innominate cannulation using a 12- or 14-Fr cannula
| Side graft | Direct cannulation | ||||
|---|---|---|---|---|---|
| Absolute value | Percentage | Absolute value | Percentage | ||
|
| 171 | 40 | – | ||
| Cardiopulmonary bypass time (min) | 154.9 ± 56.2 | 132.7 ± 40.7 |
| ||
| Cross-clamp time (min) | 104.8 ± 51.7 | 93.9 ± 34.1 | 0.202 | ||
| Circulatory arrest time (min) | 10.9 ± 6.0 | 8.1 ± 1.9 |
| ||
| Nadir bladder temperature (°C) | 27.2 ± 1.2 | 27.6 ± 0.7 | 0.088 | ||
|
| |||||
| Total | 4.7 ± 6.8 | 3.5 ± 3.5 | 0.269 | ||
| Packed red blood cells | 0.7 ± 2.4 | 0.6 ± 1.3 | 0.771 | ||
| Fresh-frozen plasma | 2.7 ± 3.8 | 1.8 ± 1.9 | 0.146 | ||
| Platelets | 1.3 ± 1.2 | 1.1 ± 1.0 | 0.258 | ||
| Length of stay (d) | 7.3 ± 7.9 | 8.3 ± 4.6 | 0.456 | ||
| Stroke | 4 | 2.3 | 1 | 2.5 | > 0.999 |
| Delirium | 9 | 5.3 | 5 | 12.5 | 0.149 |
| Renal failure | 2 | 1.2 | 1 | 2.5 | 0.470 |
| Myocardial infarction | 0 | 0.0 | 0 | 0.0 | > 0.999 |
| Pneumonia | 3 | 1.8 | 1 | 2.5 | 0.572 |
| Respiratory failure | 4 | 2.3 | 2 | 5.0 | 0.319 |
| Operative re-exploration | 11 | 6.4 | 3 | 7.5 | 0.732 |
| Postoperative death | 2 | 1.2 | 1 | 2.5 | 0.470 |
Note: Values are presented as mean ± standard deviation (SD) unless otherwise specified.